The ISIDORe consortium proposes to assemble the largest and most diverse research and service-providing instrument to study infectious diseases in Europe, with expertise from structural biology to clinical trials.
Pirbright will provide transnational access to virus stains.
The ISIDORe consortium will improve Europe’s global service and research capacities by becoming a key, ERA-embedded instrument for supporting research on epidemic-prone pathogens, and aims at:
- contributing to fighting the rise of the SARS-CoV-2 variants through a global, integrated and challenge-driven approach by providing fast access to cutting-edge resources and services to scientific user communities for supporting the evidence-based development or adaptation of countermeasures in times of emergency, and
- contributing to Europe’s readiness to any epidemic-prone pathogen through a global, integrated and preparedness-driven approach by providing access to cutting-edge resources and services to scientific user communities for supporting their research projects in the field of infectious diseases in “peaceful times” as well as during epidemics.
